» Articles » PMID: 35232298

Emergency Department Use by Persons with MS: A Population-based Descriptive Study with a Focus on Infection-related Visits

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2022 Mar 2
PMID 35232298
Authors
Affiliations
Soon will be listed here.
Abstract

We described emergency department (ED) visits (all visits and infection-related) by persons with multiple sclerosis (MS) in British Columbia, Canada (1 April 2012 to 31 December 2017). We identified 15,350 MS cases using health administrative data; 73.4% were women, averaging 51.4 years at study entry. Over 4.9 years of follow-up (mean), 56.0% of MS cases visited an ED (mean = 0.6 visits/person/year; total = 37,072 visits). A diagnosis was documented for 25,698 (69.3%) ED visits, and 18.4% (4725/25,698) were infection-related. Inpatient admissions were reported for 20.4% (5238/25,698) of all and 29.2% (1380/4725) of infection-related ED visits. Findings suggest that the ED plays a substantial role in MS healthcare and infection management.

Citing Articles

Patterns of multiple sclerosis presentation to the emergency department.

Makkawi S, Maglan A, Khojah O, Allaf F, Alamoudi S, Ahmed M Front Neurol. 2024; 15:1395822.

PMID: 38737348 PMC: 11082281. DOI: 10.3389/fneur.2024.1395822.


Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study.

Graf J, Ng H, Zhu F, Zhao Y, Wijnands J, Evans C Lancet Reg Health Am. 2024; 29:100667.

PMID: 38269206 PMC: 10806332. DOI: 10.1016/j.lana.2023.100667.

References
1.
Marrie R, Bernstein C, Peschken C, Hitchon C, Chen H, Fransoo R . Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality. Neurology. 2014; 82(23):2112-9. PMC: 4118502. DOI: 10.1212/WNL.0000000000000495. View

2.
Oynhausen S, Alcauskas M, Hannigan C, Bencosme Y, Muller M, Lublin F . Emergency medical care of multiple sclerosis patients: primary data from the mount sinai resource utilization in multiple sclerosis project. J Clin Neurol. 2014; 10(3):216-21. PMC: 4101098. DOI: 10.3988/jcn.2014.10.3.216. View

3.
Quan H, Parsons G, Ghali W . Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care. 2002; 40(8):675-85. DOI: 10.1097/00005650-200208000-00007. View

4.
Rotstein D, Marrie R, Tu K, Schultz S, Fung K, Maxwell C . Health service utilization in immigrants with multiple sclerosis. PLoS One. 2020; 15(7):e0234876. PMC: 7347150. DOI: 10.1371/journal.pone.0234876. View

5.
Ng H, Zhu F, Kingwell E, Zhao Y, Yao S, Ekuma O . Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting. Expert Rev Neurother. 2020; 21(1):131-140. DOI: 10.1080/14737175.2021.1847085. View